upsid announc acquisit
view report acceler organ growth upsid
result highlight compani continu shift softwar
integr payment addit compani announc
acquisit advancedmd saas-softwar provid physician
result adjust ep estim
street total net revenu y/
forecast adjust oper margin net
revenu y/i forecast
attribut ep beat lower-than-expect tax rate
advancedmd acquisit continu recent acquisit histori
announc acquisit advancedmd marlin equiti partner
close anticip advancedmd provid saa
softwar solut small-to-mids us ambulatori practic
confer call manag note advancedmd largest
provid cloud-bas solut highli fragment market
gener revenu grow doubl
digit accret ep
north america north american revenu y/i
acceler last quarter adjust cash-oper
margin y/i synergi revenu mix
organ growth technology-driven direct busi channel accord
manag us direct busi deliv low double-digit y/i
organ net revenu growth acceler especi
integr vertic channel
midpoint rang follow solid perform
quarter estim revenu guidanc remain
unchang increas fx headwind counteract busi momentum
guidanc call adjust net revenu includ network fee
unchang adjust ep
oper margin expans unchang
rais ep estim target price reflect quarterli
perform updat guidanc acquisit rais
ep estim ep estim
higher forward estim increas target
price multipl ep estim
near high end histor valuat rang indic
increas softwar mix revenu peer
price intra-day et
revenu revenu restat reflect
revenu revenu net basi
ep dilut ep shown cash basi
ep dilut result calendar year basi
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
lead provid technology-en
payment servic merchant partner
countri throughout north america europ asia-pacif
potenti catalyst near term includ
addit possibl compani de-lev
heartland deal contempl model
could drive upsid number
continu posit mix shift technolog driven direct
distribut drive faster organ growth core
slowdown payment volum lower contribut
margin intern oper increas
competit beyond contempl model
could pose risk price target object rate
bloomberg capit market estim upside/downside/target
price target roughli ep
estim base case multipl premium
target multipl warrant compani multi-
year shift higher-margin faster-grow revenu
intern market line compar
compani underli ep estim expect
high-single-digit revenu growth base growth
us-driven integr payment busi stabl
canadian market european growth driven especi
spain e-commerce asia pac growth price
target support outperform rate
upsid scenario valuat upsid
ep estim premium current estim
believ appropri earn surpris upsid
upsid potenti assum acceler revenu growth
driven sign addit process contract
portfolio acceler mix shift technolog
driven platform addit better-than-
downsid scenario valuat downsid
ep estim discount current estim
five-point multipl reduct believ appropri
earn surpris downsid would call
question stabil compani oper margin
downsid potenti assum deceler revenu
growth low single-digit level driven slower
convers integr payment model north america
macro headwind foreign market and/or north
adjust ep estim street total
net revenu y/i forecast north america post
revenu forecast europ
forecast asia-pacif adjust oper margin net
revenu y/i forecast north american
oper margin increas y/i forecast european margin
increas y/i forecast asia-pacif margin
y/i forecast attribut ep beat lower-than-
detail quarter includ
guidanc manag increas adjust ep guidanc midpoint
rang follow solid perform quarter estim
revenu guidanc remain unchang increas fx headwind counteract
busi momentum midpoint guidanc result revenu growth
adjust ep growth rel
advancedmd acquisit continu recent acquisit histori announc
acquisit advancedmd marlin equiti partner close
anticip advancedmd provid saa softwar solut small-to-mids
us ambulatori practic confer call manag note advancedmd
largest provid cloud-bas solut highli fragment market
gener revenu grow doubl digit
accret ep furthermor alreadi process advancedmd
annual payment volum acquisit softwar revenu compris
gpn total revenu
north american revenu y/i acceler last quarter
adjust cash-oper margin y/i synergi revenu mix
organ growth technology-driven direct busi channel accord
manag us direct busi deliv low double-digit y/i organ net revenu
growth acceler especi integr vertic channel
iso busi declin low doubl digit versu high-singl declin last
quarter canada stabl grew line expect
european revenu growth y/i double-digit fxn organ revenu growth
strength spain erst jv central eastern europ gpn e-commerce
omnichannel busi adjust cash-oper margin versu
estim last year confer call manag note uk
perform well market share gain despit challeng macro environ amid
brexit concern price uk gener transpar competit
interchange-plu basi
asia-pacif continu solid perform estim y/i report
revenu growth adjust cash oper margin y/i hong kong
philippin taiwan saw solid trend accord manag ezidebit
eway solut continu perform well
free cash flow capit alloc gener free cash flow
quarter repurchas share addit compani complet
debt refinanc reduc effect interest cost increas
amount avail compani revolv
guidanc call adjust net revenu includ network fee
unchang adjust ep oper
exhibit earn summari comparison million except per share amount
inc earn model comparison million except per share amount merchant merchant tax incom ep vs expectationsprior year payment processor servic
price target roughli ep estim multipl base
case valuat premium share histor averag multipl
believ target multipl warrant compani multi-year shift higher-margin
faster-grow revenu integr payment intern market potenti upsid
compani fundament could provid increment valu price target support
outperform rate
risk rate price target
slowdown payment volum lower contribut margin intern
oper increas competit beyond contempl model could
risk price target object rate increas regulatori scrutini inabl
maintain price structur prolong global recess could caus stock perform
expect pose risk achiev price target object
rate
lead provid technolog driven payment servic merchant
partner countri throughout north america europ asia-pacif brazil
million
total revenu
total revenu
total revenu
total ebit
total ebit
total ebit
sale
interest incom
interest expens
net income/ expens
net incom
compani data capit market estim
